These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12841205)

  • 1. Protein phosphorylation drug discovery summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USA.
    Stokoe D
    IDrugs; 2003 May; 6(5):432-6. PubMed ID: 12841205
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein Phosphorylation Drug Discovery Summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USA.
    Hooft R
    IDrugs; 2003 Apr; 6(4):312-4. PubMed ID: 12839006
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic Diseases Drug Discovery World Summit--SRI conference. 28-29 July 2003 San Diego, CA, USA.
    Knittel T
    IDrugs; 2003 Sep; 6(9):845-9. PubMed ID: 14565169
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
    Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
    Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and dephosphorylation of protein in regulating cellular function.
    Kurosawa M
    J Pharmacol Toxicol Methods; 1994 Jun; 31(3):135-9. PubMed ID: 8068974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract]   [Full Text] [Related]  

  • 7. 10th anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit. 20-21 March 2006, New Brunswick, USA.
    Braddock M; Murray C
    Expert Opin Investig Drugs; 2006 Jun; 15(6):721-7. PubMed ID: 16732722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinases and phosphatases: regulation by autoinhibitory domains.
    Soderling TR
    Biotechnol Appl Biochem; 1993 Oct; 18(2):185-200. PubMed ID: 8251116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. PPAR and PTB1B modulators 26-27 July 2004, San Diego, CA, USA.
    Xu J
    IDrugs; 2004 Sep; 7(9):836-8. PubMed ID: 15470599
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to assess phosphoprotein phosphatase and protein kinase-mediated regulation of the cytoskeleton.
    Eriksson JE; Toivola DM; Sahlgren C; Mikhailov A; Härmälä-Braskén AS
    Methods Enzymol; 1998; 298():542-69. PubMed ID: 9751907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protein phosphatases: structure and function].
    Bulanova EG; Budagian VM
    Mol Biol (Mosk); 1994; 28(5):991-1001. PubMed ID: 7990844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin kinase II as a target for inhibition in cardiac disease.
    Doggrell SA
    Expert Opin Ther Targets; 2005 Dec; 9(6):1319-21. PubMed ID: 16300478
    [No Abstract]   [Full Text] [Related]  

  • 13. 4D-networking by mitotic phosphatases.
    Qian J; Winkler C; Bollen M
    Curr Opin Cell Biol; 2013 Dec; 25(6):697-703. PubMed ID: 23849679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
    Mackonochie M
    IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
    [No Abstract]   [Full Text] [Related]  

  • 15. Cambridge Healthtech Institute Signal Transduction Conference: targets for effective therapeutics.
    Wong BR
    Expert Opin Investig Drugs; 2005 Feb; 14(2):209-14. PubMed ID: 15757398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory effects of S-100 protein and parvalbumin on protein kinases and phosphoprotein phosphatases from brain and skeletal muscle.
    Kuo WN; Blake T; Cheema IR; Dominguez J; Nicholson J; Puente K; Shells P; Lowery J
    Mol Cell Biochem; 1986 Jun; 71(1):19-24. PubMed ID: 3014310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional approach to questions about life, death, and phosphorylation.
    Bernards R
    Cancer Cell; 2005 Jun; 7(6):503-4. PubMed ID: 15950899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Protein Kinases and Phosphatases Coupled to Glutamate Receptors Regulates the Phosphorylation State of DARPP32 at Threonine 75 After Repeated Exposure to Cocaine in the Rat Dorsal Striatum in a Ca2+-Dependent Manner.
    Kim J; Ryu IS; Seo SY; Choe ES
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26142455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma bound to endothelial cells is phosphorylated by ecto-protein kinases.
    Al-Nedawi KN; Pawłowska Z; Cierniewski CS
    Acta Biochim Pol; 1999; 46(3):693-702. PubMed ID: 10698277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinases and phosphatases that act on histidine, lysine, or arginine residues in eukaryotic proteins: a possible regulator of the mitogen-activated protein kinase cascade.
    Matthews HR
    Pharmacol Ther; 1995; 67(3):323-50. PubMed ID: 8577821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.